Skip to content

13F-HR filed by Iron Triangle Partners LP

Iron Triangle Partners LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 25 holding rows worth $703,275,733.

Accession
0001172661-25-004856
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 25 entries on the cover page, a total value of $703,275,733 stated on the cover page (in dollars after the unit check, H1), rows summing to $703,275,733 with VALUE read as dollars as filed, 13F file number 028-20024. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CVS Health Corporation126650100COM797,900$60,153,681dollars as filed
DEXCOM INC COM252131107Stock850,000$57,196,500dollars as filed
AbbVie,Inc.00287Y109COM200,326$46,383,482dollars as filed
Medtronic PlcG5960L103COM453,347$43,176,768dollars as filed
CHARLES RIV LABS INTL INC159864107COM268,000$41,931,280dollars as filed
Eli Lilly and Company532457108COM49,555$37,810,465dollars as filed
BRIGHTSPRING HEALTH SVCS10950A106COM1,238,520$36,610,651dollars as filed
REPLIGEN CORP COM759916109Stock270,000$36,090,900dollars as filed
GLAUKOS CORP COM377322102Stock342,804$27,955,666dollars as filed
TENET HEALTHCARE CORP COM NEW88033G407Stock137,448$27,907,442dollars as filed
EXACT SCIENCES CORP COM30063P105Stock500,000$27,355,000dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock1,820,915$27,240,888dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock58,378$26,775,653dollars as filed
GUARDANT HEALTH INC COM40131M109Stock400,000$24,992,000dollars as filed
BROOKDALE SR LIVING INC112463104COM2,838,361$24,040,918dollars as filed
CARDINAL HEALTH INC14149Y108COM138,011$21,662,207dollars as filed
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock150,000$19,770,000dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM131,390$18,444,528dollars as filed
WEST PHARMACEUTICAL SVSC INC COM955306105Stock70,000$18,363,100dollars as filed
ADAPTHEALTH CORP00653Q102COMMON STOCK1,924,132$17,220,981dollars as filed
VERACYTE INC COM92337F107Stock485,000$16,650,050dollars as filed
AMICUS THERAPEUTICS INC03152W109COM1,971,260$15,533,529dollars as filed
DOXIMITY INC CL A26622P107Stock210,000$15,361,500dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock270,000$7,346,700dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR9,900$7,301,844dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-25-004856this filing2025-11-14acceptance time not in the bulk data set